Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
The Centers for Medicare & Medicaid Services April 27 issued guidance on the process the agency will use to review and approve state demonstration projects under Medicaid and the Children's Health Insurance Program (CHIP).
The guidance explains how CMS plans to implement a final rule it issued in February that sets out requirements for improving public input and transparency in the process the agency uses to handle requests by states to conduct demonstration projects (35 HCDR, 2/23/12).
The demonstration projects, authorized under Section 1115 of the Social Security Act, allow states to test new coverage and delivery models after obtaining so-called Section 1115 waivers from CMS.
Medicaid stakeholders have complained for years about a lack of public input into the design of state demonstration projects authorized under Section 1115 waivers. The final rule, which became effective April 27, applies to applications for new demonstration projects and applications for extensions of existing projects.
The CMS guidance, which was issued along with a letter to state Medicaid directors, explains that CMS is making available a user guide for stakeholder organizations interested in participating in the enhanced public notice and comment process the final rule requires.
The user guide is designed to assist interested parties in navigating a new part of the CMS website, where information about approved and pending Section 1115 waiver applications is available for review.
In addition, the guide provides information about how to access the public comment feature for pending demonstration applications and amendment requests, CMS said.
CMS said it will also post on its website state applications for Section 1115 waivers and will enable the public to submit comments on a specific application.
In the final rule, CMS said it will not make a final decision on a state application until 45 days after it is complete, to allow CMS to consider public comments submitted during a 30-day comment period.
After approval of a demonstration project, CMS said it will maintain and publish on its website an administrative record that will include the demonstration application, public comments sent to CMS and, if the application is approved, final special terms and conditions for the project
The CMS guidance, along with links to the letter to Medicaid directors and the CMS user guide, is at http://op.bna.com/hl.nsf/r?Open=bbrk-8trt6g.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)